Cargando…
IgM Deficiency in Autoimmune Blistering Mucocutaneous Diseases Following Various Treatments: Long Term Follow-Up and Relevant Observations
IgM deficiency has been reported in patients with many autoimmune diseases treated with Rituximab (RTX). It has not been studied, in detail, in autoimmune mucocutaneous blistering diseases (AIMBD). Our objectives were: (i) Examine the dynamics of IgM levels in patients with and without RTX. (ii) Inf...
Autores principales: | Ahmed, A. Razzaque, Aksoy, Merve |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504479/ https://www.ncbi.nlm.nih.gov/pubmed/34646266 http://dx.doi.org/10.3389/fimmu.2021.727520 |
Ejemplares similares
-
Editorial: Autoimmune Blistering Diseases
por: Kowalewski, Cezary, et al.
Publicado: (2020) -
Selective IgM Deficiency—An Underestimated Primary Immunodeficiency
por: Gupta, Sudhir, et al.
Publicado: (2017) -
Anti-Desmocollin Autoantibodies in Autoimmune Blistering Diseases
por: Bosch-Amate, Xavier, et al.
Publicado: (2021) -
Editorial: Autoimmune blistering diseases, volume II
por: Li, Xiaoguang, et al.
Publicado: (2023) -
Chronic Mucocutaneous Candidiasis in Autoimmune Polyendocrine Syndrome Type 1
por: Humbert, Linda, et al.
Publicado: (2018)